InspireMD Net Worth

InspireMD Net Worth Breakdown

  NSPR
The net worth of InspireMD is the difference between its total assets and liabilities. InspireMD's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of InspireMD's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. InspireMD's net worth can be used as a measure of its financial health and stability which can help investors to decide if InspireMD is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in InspireMD stock.

InspireMD Net Worth Analysis

InspireMD's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including InspireMD's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of InspireMD's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform InspireMD's net worth analysis. One common approach is to calculate InspireMD's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares InspireMD's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing InspireMD's net worth. This approach calculates the present value of InspireMD's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of InspireMD's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate InspireMD's net worth. This involves comparing InspireMD's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into InspireMD's net worth relative to its peers.
To determine if InspireMD is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding InspireMD's net worth research are outlined below:
InspireMD had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 6.21 M. Net Loss for the year was (19.92 M) with profit before overhead, payroll, taxes, and interest of 1.12 M.
InspireMD currently holds about 26.47 M in cash with (16.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.18, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 17.0% of the company outstanding shares are owned by corporate insiders
InspireMD uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in InspireMD. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to InspireMD's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Follow InspireMD's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 72.25 M.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific InspireMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on InspireMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases InspireMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
InspireMD time-series forecasting models is one of many InspireMD's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary InspireMD's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

InspireMD Earnings per Share Projection vs Actual

InspireMD Corporate Management

Shane GleasonChief OfficerProfile
Roei SamuriVP OperationsProfile
DVM MDExecutive AffairsProfile
Andrea TommasoliChief OfficerProfile
Amir KohenVice ResourcesProfile

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.